After a reasonable level of certainty was reached that the largest gastric lesion represented an ulcerated-type gastric carcinoma, we wanted to determine its tumor-node-metastasis (TNM) stage.
Hosted on MSN1mon
BeiGene wins FDA nod for Tevimbra in gastric cancerPreviously, the FDA had approved Tevimbra as a single agent and a late-line option for adults with unresectable or metastatic esophageal squamous cell carcinoma. BeiGene’s (NASDAQ:BGNE ...
(B) Surgically resected gastric adenocarcinoma. A positive case for any percentage of TC with 2+ to 3+ intensity membranous staining. (C) Liver core-needle biopsies, metastatic gastric adenocarcinoma.
The prognostic value of HER2 gene dosage and heterogeneity at a single-cell resolution in gastroesophageal adenocarcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers ...
Eligible patients had unresectable locally advanced or limited metastatic disease ... advanced or limited metastatic gastric or gastroesophageal junction adenocarcinoma: FDZL-001 trial" ASCO ...
CLDN18.2 is frequently overexpressed in a range of primary malignant tumors, including gastric, esophageal, cholangiocarcinoma, pancreatic and other cancers. The U.S. Food and Drug Administration ...
Topline data were announced from a phase 3 trial evaluating Keytruda plus Lenvima with chemotherapy in advanced gastroesophageal cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results